Skip to main content
Top
Published in: The journal of nutrition, health & aging 10/2019

01-12-2019

Impact of Number of Drug Types on Clinical Outcome in Patients with Acute Hip Fracture

Authors: Hiroki Maki, H. Wakabayashi, M. Nakamichi, R. Momosaki

Published in: The journal of nutrition, health & aging | Issue 10/2019

Login to get access

Abstract

Objectives

This study aims to investigate the impact of the number of drug types on clinical outcomes for patients with acute hip fracture.

Designs

This is a retrospective cross-sectional study.

Setting

A hospital-based database constructed by the Japan Medical Data Center.

Participants

Consecutive patients exhibiting acute hip fractures on admission between April 2014 and November 2017 were included.

Measurements

Relationships among the numbers of varying drug types of ≥6 and ≤5 as well as clinical outcomes were analyzed in 11,073 patients aged ≥65 years. The primary outcome was defined as the Barthel Index efficiency, with the secondary outcome being the length of hospital stay.

Results

Median Barthel Index scores at admission and discharge were 5 (interquartile range: 5–20) and 50 (interquartile range: 20–85). The Barthel Index efficiency was significantly higher in the group having received 5 or fewer drug variations taken (1.45 ± 1.77) than in the group receiving 6 or more drug types taken (0.94 ± 1.18) during hospital stays (p < 0.001). The length of hospital stay was significantly shorter in the group receiving 5 or fewer drug types taken (29.9 ± 23.8) than in the group having 6 or more drug types taken (44.3 ± 30.3) during hospital stays (p < 0.001), with the latter number being independently associated with the Barthel Index efficiency and length of hospital stay.

Conclusions

Number of drug types of 6 or more were associated with lower Barthel Index efficiency and longer lengths of hospital stays.
Literature
4.
go back to reference Suzuki Y, Akishita M, Arai H, Teramoto S, Morimoto S, Toba K. Multiple consultations and polypharmacy of patients attending geriatric outpatient units of university hospitals. Geriatr Gerontol Int 2006;6, 244–247.CrossRef Suzuki Y, Akishita M, Arai H, Teramoto S, Morimoto S, Toba K. Multiple consultations and polypharmacy of patients attending geriatric outpatient units of university hospitals. Geriatr Gerontol Int 2006;6, 244–247.CrossRef
17.
go back to reference Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. Md State Med J 1965;14, 61–65.PubMed Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. Md State Med J 1965;14, 61–65.PubMed
18.
22.
go back to reference Koval KJ, Chen AL, Aharonoff GB, Egol KA, Zuckerman JD. Clinical pathway for hip fractures in the elderly: the Hospital for Joint Diseases experience. Clin Orthop Relat Res 2004;425, 72–81.CrossRef Koval KJ, Chen AL, Aharonoff GB, Egol KA, Zuckerman JD. Clinical pathway for hip fractures in the elderly: the Hospital for Joint Diseases experience. Clin Orthop Relat Res 2004;425, 72–81.CrossRef
Metadata
Title
Impact of Number of Drug Types on Clinical Outcome in Patients with Acute Hip Fracture
Authors
Hiroki Maki
H. Wakabayashi
M. Nakamichi
R. Momosaki
Publication date
01-12-2019
Publisher
Springer Paris
Published in
The journal of nutrition, health & aging / Issue 10/2019
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-019-1250-6

Other articles of this Issue 10/2019

The journal of nutrition, health & aging 10/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.